Ferric Gluconate Package Insert: Usage, Dosage, and Safety Guidelines

application 2025-11-09

Ferric Gluconate Package Insert: Essential Information for Safe Use

Introduction
Ferric gluconate is an intravenous iron supplement used to treat iron deficiency anemia in patients with chronic kidney disease (CKD) or other conditions requiring rapid iron replenishment. This package insert provides key details on dosage, administration, side effects, and precautions to ensure safe and effective treatment.

Indications and Usage
Ferric gluconate is indicated for:
– Iron deficiency anemia in CKD patients undergoing hemodialysis.
– Patients intolerant to oral iron therapy.
– Individuals requiring rapid iron correction before surgery or other medical interventions.

Dosage and Administration
– Adults: Typically 125 mg administered intravenously during dialysis sessions.
– Dosage Adjustment: Based on hemoglobin levels and iron parameters.
– Administration: Must be diluted and given as a slow IV infusion to minimize adverse reactions.

Warnings and Precautions
– Hypersensitivity: Monitor for allergic reactions, including anaphylaxis.
– Hypotension: May occur during infusion; monitor blood pressure.
– Iron Overload: Excessive administration can lead to hemosiderosis.

Adverse Reactions
Common side effects include:
– Nausea, vomiting
– Headache, dizziness
– Flushing, hypotension
– Muscle cramps

Drug Interactions
– May reduce absorption of oral iron supplements.
– Concomitant use with ACE inhibitors may increase hypersensitivity risk.

Storage and Handling
– Store at controlled room temperature (20–25°C).
– Protect from light and freezing.

Conclusion
Ferric gluconate is an effective treatment for iron deficiency anemia but requires careful administration and monitoring. Always follow medical guidelines and consult healthcare professionals for personalized dosing.